Jiangsu Longliqi Biotechnology Co., Ltd. (“Longliqi” or the “Company”) is a leading biotechnology company based in Jiangsu, China. Founded in 2001, Longliqi has grown to become one of the most successful enterprises in the biotechnology industry, with more than 500 employees across seven research centers.
Longliqi is committed to the development of innovative biotechnologies, such as genetic engineering, cell-based medicine and bioinformatics. It has a range of products from reformulate traditional pharmaceuticals, to novel cancer treatments, to diagnostics and medical consumables, as well as technology solutions for the biotechnology industry. Longliqi’s core focus is on the development of novel therapies that cure and / or improve the quality of life for patients with serious diseases.
The Company employs a team of experienced scientists who are focused on developing innovative and novel therapies for rare diseases such as acute leukemia and cystic fibrosis. Its extensive research and development has enabled Longliqi to develop several early stage clinical trials involving novel therapies for rare, orphan and other diseases. The Company has also filed numerous patents in the United States and Europe and has been granted various awards and recognitions for its contributions to the biotechnology industry.
In addition to investing in its research and development, Longliqi is also involved in product manufacturing and marketing, as well as in building partnerships with other companies in order to facilitate the rapid commercialization of its technologies. The Company has established research collaborations with various universities and research institutions, in order to enhance its understanding of the field and drive innovation. Longliqi also seeks to expand its presence through strategic alliances with other biotechnology companies, in order to facilitate joint product development, technology transfer, and licensing opportunities.
Longliqi is committed to fostering a culture that encourages creativity, initiative and collaboration. Its employees value integrity, respect and dedication, which contribute to an environment that encourages the full development of ideas and teams. Longliqi’s core vision is to be the leading provider of therapies and technologies in the biotechnology market, enabling its clients to achieve sustainable health outcomes and improved quality of life.
